One Health News

Search News:
Found 852 Matching Results. View archived News Here.

‘One Health in Action’...2017 American Academy of Dermatology (physicians, veterinarians and other health scientists) – New York, N.Y. - Saturday, August 05, 2017

‘One Health in Action’...2017 American Academy of Dermatology (physicians, veterinarians and other health scientists) – New York, N.Y.

“Future research collaborations between veterinarians and physician scientists to improve the treatment for chronic itch and atopic dermatitis will result in a better understanding of pathophysiology and treatment responses for humans and canines alike. This is truly the spirit of One Health.”

Jennifer M. Gardner, MD

Assistant Professor, Division of Dermatology

University of Washington

Collaborating Member, UW Center for One Health Research (COHR)

Seattle Cancer Care Alliance, Melanoma and Skin Oncology

Provided by Dr. Gardner to the One Health Initiative website August 4, 2017.


Left to right:  Jennifer Gardner, MD; Daniel Morris, DVM, MPH; Elizabeth Grice, PhD; Kathryn Rook, VMD; Charles Bradley, VMD; Brian Kim, MD.  Not pictured: Dirk Elston, MD.


At the 2017 American Academy of Dermatology Summer meeting held in New York City, the new forum entitled “Comparative Dermatology: cases at the intersection of human and veterinary [medical] dermatology and the One Health Paradigm” featured physician dermatologists, veterinarian dermatologists and dermatopathologists and scientists at the podium and asked how can a collaborative approach across these disciplines help us understand our own skin health better? The forum was conceived through collaboration between Dr. Jennifer Gardner, Assistant Professor of Dermatology at the University of Washington in Seattle and Collaborating Member of the UW Center for One Health Research and Dr. Dan Morris, Professor of Dermatology & Allergy at the University of Pennsylvania School of Veterinary Medicine. Dr. Gardner provided a short introduction defining “One Health” for the audience and described how using the One Health paradigm can reveal connections between human health, animals and the shared environment. Then three pairs of experts explored topics as they related to OH and dermatology.

First up, Dr. Dirk Elston, Chairman of Dermatology at the Medical University of South Carolina, shared an update regarding Demodex, a.k.a. “the follicle mite, in humans, including skin disorders associated with overgrowth of this usually symbiotic ectoparasite. He also discussed treatment of these problems when our mites are behaving badly. His favorite therapy turns out to be an oldie but still goodie: sulfur.

Dr. Kathryn Rook, a veterinary [medical] dermatologist at the University of Pennsylvania School of Veterinary Medicine, shared news about a revolution in veterinary [medical] clinics regarding treatment of Demodex mites in dogs and cats, which are not zoonotic, meaning demodectic mange doesn’t get passed from family pets to their humans. Considering the veterinary [medical] world is decades ahead of human medicine with regard to anti-ectoparasitic strategies, it’s worth looking to veterinarians to see what might be coming down the pipeline for humans. A new class of drugs currently licensed in the U.S. for flea and tick prevention in dogs and cats, have been practice-changing when used off-label for the treatment of demodicosis in dogs and cats. Isoxazolines are GABA receptor antagonists leading to paralysis and subsequent death of insects. These medications have resulted in quicker resolution of skin symptoms. There has been a rapid rise in the use of these compounds, which means there is a new chemical in the shared environment that could leave a residue, though whether that holds risk for humans or other animals is as of yet, unknown. 

Next up, we explored a powerful but simple tool in One Health: asking the question, “Do dogs get atopic dermatitis?” It turns out, they absolutely do! And, currently, naturally occurring canine atopic dermatitis (AD) is likely the most established large animal model (i.e. non-mouse model) of human disease in dermatology. By identifying these similarities we can ask how looking to “man’s best friend” can tell us a lot about our own skin. Dr. Charles Bradley, a veterinary dermatopathologist at the University of Pennsylvania School of Veterinary Medicine and Dr. Elizabeth Grice, a microbiologist in the Department of Dermatology at the University of Pennsylvania, shared results from their collaboration characterizing the skin microbiome (genetic analysis of the microbial species, in this case bacterial communities, present on the skin) of dogs with AD. What they found mirrored the findings in human pediatric AD, previously characterized by Dr. Heidi Kong’s group at the NIH. By researching the skin microbiome of dogs, we may learn more about ways we can better predict disease progression and novel treatment strategies that could easily translate to healthier skin for humans. This opens the doors for translational research opportunities that go beyond “the mouse trap.” By using large animal models, like dogs, who naturally suffer from similar conditions as humans and who share the same household environment, it’s likely we can derive an even better understanding of how a given treatment strategy would perform for our own skin problems. This approach has the power to improve the heath of both species: a “win-win.”

Last up at the podium, a [physician] dermatologist and scientist, Dr. Brian Kim, the Co-Director for the Center for the Study of Itch at Washington University in St. Louis gave us a preview of his lab’s recent breakthroughs, accepted for publication in the journal Cell. His lab has identified that classical molecules ascribed to the immune system, IL-4 receptor alpha and JAK1, are also functional in the nervous system and critically mediate itch. Human patients that are on drugs to block these molecules enjoy a dramatic improvement in their symptom of itch. He anticipates by designing drugs that are more selective against these neuronal pathways, the paradigm will change when it comes to treating humans with chronic itch.

Dr. Kim’s talk was the perfect segue for Dr. Morris to discuss the veterinary [medical] experience using such targeted systemic therapies for the treatment of pruritus and atopic dermatitis in canines. Having patients covered in fur limits the use of topical therapies, first line approaches for treating atopic dermatitis in humans. Thus, veterinarians are 5-6 years ahead of human dermatology in using these treatment strategies. Dr. Morris discussed the JAK-1 inhibitor, oclacitinib, in treating his patients with these conditions. He then told the audience about lokivetmab, a caninized monoclonal antibody against IL-31, a mediator of itch through neuronal pathways. He provided examples of success in dogs who failed therapy with oclacitinib and discussed some limitations of IL-31 inhibitors, namely that they are good at decreasing the symptom of pruritus but do not have a good anti-inflammatory effect and may not be the answer for dogs who suffer from recurrent pyoderma. Future research collaborations between veterinarians and physician scientists to improve the treatment for chronic itch and atopic dermatitis will result in a better understanding of pathophysiology and treatment responses for humans and canines alike. This is truly the spirit of One Health.


Beugnet F, Halos L, et al. Efficacy of oral afoxolaner for the treatment of canine generalized demodicosis. Parasite (2016) 23:14.

Bradley CW, Morris DO, Rankin SC, Cain CL, Misic AM, Houser T, et al. Longitudinal Evaluation of the Skin Microbiome and Association with Microenvironment and Treatment in Canine Atopic Dermatitis. J Invest Dermatol. 2016;136(6):1182-90.

Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet Dermatol 2015; 26: 171–e35.

Fourie JJ, Liebenberg JE, et al. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs. Parasites & Vectors. (2015) 8:187.

Gadeyne C, Little P, King VL, et al. Efficacy of oclacitinib (Apoquel) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. Vet Dermatol 2014; 25: 512–e86.

Gassel M, Wolf C, et al. The novel isoxazoline ectoparasiticide fluralaner: Selective inhibition of arthropod 𝛾-aminobutyric acid- and 𝐿-glutamate-gated chloride channels and insecticidal/acaricidal activity. Insect Biochemistry and Molecular Biology (2014) 45:111.

Gonzales AJ, Humphrey WR, Messamore JE, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 2013;24:48-e12.

Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850-9.

Little PR, King VL, Davis KR, et al. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and cyclosporine for the control of atopic dermatitis in client-owned dogs.  Vet Dermatol 2015; 26: 23–e8.

Michels GM, Ramsey DS, Walsh KF, et al. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis. Vet Dermatol 2016; 27: 478–e129.

Mizuno T, Kanbayashi S, Okawa T, et al. Molecular cloning of canine interleukin-31 and its expression in various tissues. Vet Immunol Immunopathol 2009;131:140-3.

Weber T, Selzer PM. Isoxazolines: A novel chemotype highly effective on ectoparasites. Chem Med Chem 2016;11:270-6.

One health approach recognized in China's national science magazine - Friday, August 04, 2017

One health approach recognized in China's national science magazine


Human health and animal health are intimately related and the one-health approach is the only way to tackle emerging infectious diseases in a globalized world.”


Gregory C. Gray, MD, MPH, FIDSA

Duke Medicine

Professor, Division of Infectious Diseases, Global Health Institute, & Nicholas School of the Environment, Duke University

DUMC Box 102359, Durham, NC 27710

Tel: +1-919-684-1032

Duke-NUS Medical School, Singapore

Professor, Program in Emerging Infectious Diseases

8 College Road, Singapore 169857

Tel: +65-16-7666

Duke Kunshan University, China

Professor, Global Health

No. 8 Duke Avenue, Kunshan, Jiangsu, China 215316

Tel: +86-400-892-0508

Duke One Health:      Email:

See: “One world, one health: combating infectious diseases in the age of globalization”: National Science Review, Volume 4, Issue 3, 1 May 2017, Pages 493–499.

Note: Dr. Gray is a member of the One Health Initiative team’s Advisory Board

Strengthening the Implementation of One Health Principles - Chatham House - Thursday, August 03, 2017

Chatham House


An independent policy institute with a mission to help build a sustainably secure, prosperous and just world. 

Strengthening the Implementation of One Health Principles

This project aims to assess the potential benefits of establishing One Health platforms and centres of excellence in both high–income and low- and middle-income settings.

Please see

Gold Headed Cane Awarded to One Health Initiative Team Member – Dr. Lisa A. Conti - Monday, July 31, 2017

Dr. Craig N. Carter, left presenting American Veterinary Epidemiology Society (AVES) Gold Headed Cane to Dr. Lisa A. Conti, right.

2017 Gold Headed Cane Awarded to One Health Initiative Team Member – Dr. Lisa A. Conti 

Dr. Lisa A. Conti received the prestigious American Veterinary Epidemiology Society (AVES) KF Meyer/James H. Steele Gold Headed Cane Award from Dr. Craig N. Carter, current AVES President at the American Veterinary Medical Association convention in Indianapolis, Indiana (USA) on July 24, 2017. 
“The award was in recognition of Dr. Conti’s devotion to and achievements in the advancement of animal health, human health and One Health” said Dr. Carter.  He went on to say, “... you are so very deserving.”
Dr. Conti is currently the Deputy Commissioner and Chief Science Officer of the Florida Department of Agriculture and Consumer Services, overseeing the divisions of Food Safety, Agriculture Environmental Services, Aquaculture, Animal Industry, and Plant Industry. Prior appointments were with the Florida Department of Health for 23 years, as Division Director of Environmental Health, Florida State Public Health Veterinarian and State HIV/AIDS Surveillance Coordinator. She has authored or co-authored numerous journal articles on One Health, public health, HIV/AIDS surveillance, vector-borne and zoonotic disease topics. She is Coeditor with prominent One Health physician Dr. Peter Rabinowitz, of the book Human-Animal Medicine: Clinical Approaches to Zoonoses, Toxicants and Other Shared Health Risks  and Co-editor of Confronting Emerging Zoonoses: The One Health Paradigm
Dr. Conti serves on the NIH National Advisory Environmental Health Sciences Council. She is a member of the One Health Initiative pro bono team currently comprised of two physicians and two veterinarians. She was a founding member and Chair of the State Environmental Health Directors with the Association of State and Territorial Health Officers. She was a founding member of the Florida Rabies Control and Prevention Advisory Committee, sat on the Rabies Compendium Committee of the National Association of State Public Health Veterinarians, was an Executive Board member of the Florida Veterinary Medical Association (FVMA) and established and chaired the FVMA One Health Committee from 1995-2013. Dr. Conti served on the American Veterinary Medical Association (AVMA) Council on Public Relations representing Public Health.
She was an Affiliate with the Yale University School of Medicine on Human-Animal Medicine projects; an Adjunct Professor at Florida State University having taught Food Safety and Epidemiology courses; Courtesy Associate Professor at the University of Florida, College of Veterinary Medicine’s Department of Infectious Diseases and Pathology; and, has taught Anatomy and Physiology at Tallahassee Community College.
She earned her Doctor of Veterinary Medical degree from the University of Florida, Master of Public Health (Public Health Administration) from the University of South Florida and Bachelor of Science (Chemistry/Math) from the University of Miami. She is a Certified Public Manager through Florida State University, and Board Certified in Preventive Medicine through the American College of Veterinary Preventive Medicine.
Dr. Conti is a recipient of the Florida Public Health Woman of the Year Award and the AVMA Public Service Award.
Dr. Terry McElwain was also awarded the KF Meyer/James H. Steele Gold Headed Cane for outstanding leadership and career contributions in epidemiology, public health and One Health.  Dr. McElwain earned his DVM from Kansas State University.  After a short stint in clinical practice in Pennsylvania, he completed a residency in pathology and a PhD in Veterinary Pathology and Microbiology at Washington State University. He is a Diplomate of the American College of Veterinary Pathologists.  After serving as an assistant professor of pathology, infectious diseases, and immunology at the University of Florida and Washington State University, he became the Director and Executive Director, of the Washington Animal Disease Diagnostic Laboratory in 1993, and Director of the Animal Health Research Center in 1995, continuing in those roles until his recent retirement. He continues to serve as the Associate Director and Professor of the Paul G. Allen School for Global Animal Health at Washington State University.  He is a popular scientific speaker and a prolific researcher and writer.  He loves his students and has served on dozens of graduate student committees.  His One Health oriented research in zoonotic diseases is well recognized.  Funded by CDC, he conducted classic studies establishing strategies to prevent zoonotic diseases in Kenya.  He has received many awards and extraordinary recognition in his career to include the AAVLD E.P. Pope Award, Washington State University Faculty Member of the Year Award, AVES Diplomate status, and elected to the National Academy of Sciences, Institute of Medicine.
Others awarded an AVES Honorary Diploma for outstanding contributions in epidemiology, public health and One Health with biographical information provided by Dr. Carter included:
Dr. Terri Clark received her DVM from Auburn University. After serving 11 years as a US Army Veterinary Corps Officer, she transferred to the National Institutes of Health as a commissioned corps officer in the US Public Health Service.  Currently, she is Director of the Office of Animal Care and Use at the National Institutes of Health.  She is Diplomate of the American College of Laboratory Animal Medicine.
Dr. Jason Johnson received a MS in Biomedical Sciences and a DVM degree both from Auburn University.  After 7 years in practice, he taught 2 years at the Ross University School of Veterinary Medicine at St. Kitt’s, West Indies.  He then joined Lincoln Memorial University as Medical Director of the DeBusk Veterinary Teaching Center, College of Veterinary Medicine.  He also served as Executive Director of the Center for Animal Health in Appalachia.  Next, he became Associate Dean for Clinical Sciences and in 2016, became Dean of the LMU College of Veterinary Medicine.  He is a Diplomate of the American College of Theriogenologists.
Dr. Mo Salman received his BVMS degree from the University of Baghdad, Iraq in 1973, his MPVM B.S. degree in Animal Science in 1976 and his Doctor of Veterinary Medicine both from UC Davis.  Currently, he is Professor of Clinical Sciences and Director of the Animal Population Health Institute at Colorado State University.  He has received many awards to include Penn Veterinary World Leadership Award.  He has had a long and distinguished career in veterinary epidemiology and public health and has authored or coauthored over 300 peer reviewed articles and has served as editor of 7 books.    He is a Diplomate of the American College of Veterinary Preventive Medicine and has served as President of that organization.  He is also a Fellow of the American College of Epidemiology.
Dr. John Gibbins received his DVM degree from The Ohio State University and a MPH from the Uniformed Services University of Health Sciences in Bethesda, MD.  After five years in private practice, he has served in various leadership roles of increasing responsibility in the USAF and CDC to include a stint as an Epidemic Intelligence Officer.  He is currently the 11th Chief Veterinary Officer of the United States Public Health Service.  He deployed to Liberia in 2014-2015 as part of the Ebola response team.  He is a Diplomate of the American College of Veterinary Preventive Medicine.
Dr. Paul Gibbs earned his Bachelor of Veterinary Science (DVM equivalent) and a PhD in Virology from the University of Bristol School of Veterinary Science.  He is a member and a Fellow of the Royal College of Veterinary Surgeons.  He has worked at the Pirbright Institute as a virology research officer, Professor of Virology and Chief of Microbiology and Parasitology at the University of Florida College of Veterinary Medicine and also served as the Director of the International Center for the University of Florida.   He retired in 2012.  His professional focus has always been on the control and prevention of emerging animal diseases of viral etiology. He received many honors to include the Pioneer in Virology Award from the AAVLD.
Dr. Thomas Honadel earned his DVM from Kansas State University, a MPVM from the University of California, a Masters in Strategic Studies, and a MS in Reproductive Physiology from Pennsylvania State University.  He has had a long career as a United States Army Veterinary Corps officer with leadership roles of increasing responsibility, including three command assignments in overseas locations. He is currently Director, Veterinary Services, Army Public Health Center, Aberdeen proving Ground, MD.  He has attained the rank of full Colonel and is a Diplomate of the American College of Veterinary Preventive Medicine.
Dr. Trevor Ames earned his DVM from the Western College of Veterinary Medicine at the University of Saskatchewan, Canada and completed a residency in Large Animal Medicine and a MS at the University of Minnesota.  After a stint in practice, he held positions in the Minnesota State Diagnostic Laboratory and later as a Professor of Veterinary Population Medicine with increasing levels of leadership, teaching and research responsibilities.    He is currently Dean and Professor, College of Veterinary Medicine, University of Minnesota.  He is a Diplomate of the American College of Veterinary Internal Medicine.  
Note: "Inaugurated by the American Veterinary Epidemiology Society (AVES) in 1964, the Gold Headed Cane Award was approved as an American Veterinary Medical Association (AVMA) award by the Executive Board in 1996 and is sponsored by Hartz Mountain Corporation, Secaucus, NJ (USA). The award recognizes the achievement of an individual concerned with animal health who has significantly advanced human health through the practice of veterinary epidemiology and public health. Dr. James H. Steele established the award to recognize the outstanding contributions of veterinarian, physician and scientist, Dr. Karl F. Meyer. Originally named the K.F. Meyer Gold Headed Cane Award, it was renamed the K.F. Meyer-James H. Steele Gold Headed Cane Award in 1985 to recognize Dr. Steele for his outstanding contributions to epidemiology and veterinary public health. Today, this award has gained in relevance and stature in concert with AVMA's and many other organizations' endorsement and development of the philosophy of One Health throughout the world."

Craig N. Carter, DVM, PhD, is Director & Professor, Epidemiology of the Veterinary Diagnostic Laboratory, Department of Veterinary Science in the College of Agriculture, Food & the Environment College of Public Health at University of Kentucky in Lexington, KY (USA).  Dr. Carter serves as a member of the One Health Initiative team’s Advisory Board

One Health: Vet Med Researcher Lands Grant To Study Pediatric Cancer - Saturday, July 29, 2017


Texas A&M TodayTexas A&M Today LogoTexas A&M Today


Saturday, July 29, 2017

One Health: Vet Med Researcher Lands Grant To Study Pediatric Cancer

July 27, 2017

AddThis Sharing Buttons

Share to TwitterShare to FacebookShare to PrintShare to EmailShare

Dr. Heather Wilson-Robles

Dr. Heather Wilson-Robles [a veterinarian]


By Texas A&M College of Veterinary Medicine & Biomedical Sciences Staff


Dr. Heather Wilson-Robles [DVM, DACVIM (oncology)], an associate professor and the Dr. Fred A. and Vola N. Palmer Chair in Comparative Oncology in the Texas A&M College of Veterinary Medicine & Biomedical Sciences’ (CVM) Small Animal Clinical Sciences Department, has been awarded a $94,255 research grant from the St. Baldrick’s Foundation.

“Dr. Wilson-Robles is a quintessential clinician-scholar whose independent and collaborative discoveries are carving the path to a better understanding of cancer and, ultimately, to effective cancer treatments in canine patients that will eventually translate to human patients,” said Dr. Eleanor M. Green, the Carl B. King Dean of Veterinary Medicine at Texas A&M University.

Wilson-Robles’ grant is one of 90 given to professors from across the country by St. Baldrick’s Foundation. The foundation is providing $23.5 million in its summer grant cycle to support the brightest minds in the pediatric cancer field. ...

Please read complete article at or


Editor’s note: This is a significant example (among many others) demonstrating the critical need for more rapidly recognizing and implementing the One Health approach for comparative medicine/translational medicine research.  On May 10, 2012, the American Academy of Pediatrics issued a statement to the One Health Initiative team/website endorsing One Health or

New AVMA president prioritizes leadership, workforce, One Health - Thursday, July 27, 2017


New AVMA president prioritizes leadership, workforce, One Health

Please read complete article

Promoting veterinary leadership, addressing federal veterinary workforce shortages, and leading the One Health initiative are the top priorities for the ...

Google Plus



         From Google Alerts...

American Veterinarian - "AVMA 2017: Insights for One Health from Millenia Past - Tuesday, July 25, 2017

Google Alerts

AVMA 2017: Insights for One Health from Millennia Past

American Veterinarian

“We're all in this together” was the One Health–focused theme of paleontologist and explorer Paul Sereno's keynote address during the 2017 ...

Google Plus



“Insights for One Health from Centuries and Millennia Past” - Indiana Convention Center, Indianapolis, Indiana July 22, 2017 - Friday, July 21, 2017

Insights for One Health from Centuries and Millennia Past” -  Indiana Convention Center, Indianapolis, Indiana July 22, 2017 at 10:00 a.m. 

Saturday morning American Veterinary Medical Association (AVMA) convention at July 22, 2017 Keynote Brunch 10 a.m. at the Indiana Convention Center, Indianapolis, Indiana.

Paul Sereno


Keynote speaker Paul Sereno will bring the past to life at AVMA Convention 2017

Attendees at AVMA Convention 2017 will have the opportunity to join renowned paleontologist Paul Sereno at AVMA Convention 2017 for a keynote presentation exploring how the history of the animal world relates to modern veterinary medicine. His keynote brunch address, “Insights for One Health from Centuries and Millennia Past,” promises to bring a modern angle to ancient history.

New developments in genetics, ancient DNA, fossil discoveries, and research into human development are changing our perspective on what actually happened in the past. From human-animal health crises to the timing of evolutionary changes, Sereno will bring ancient history alive to inform our current veterinary work.

Paul Sereno is a National Geographic Explorer and internationally acclaimed professor at the University of Chicago who has explored the Sahara and Gobi Deserts, India’s Thar Desert and remote valleys in Tibet. His work is an exciting blend of art, history and science wrapped in adventure, and we’re excited that he has agreed to give this keynote presentation at AVMA Convention 2017.

The keynote brunch will take place on Saturday, July 22, at 10 A.M., and is open to full convention registrants including veterinarians, technicians, practice staff and students. Guests and exhibitors are invited to attend a viewing party in an alternate location.

Interested in attending AVMA Convention 2017? You can learn more about convention events and CE highlights, and book your hotel room now, at Registration will open in February, so Follow AVMA Convention on Twitter and Facebook for the latest updates.

Note: The American Veterinary Medical Association, founded in 1863, is a not-for-profit association representing more than 89,000 U.S. veterinarians working in private and corporate practice, government, industry, academia, and uniformed services.

Associated One Health initiatives - Monday, July 17, 2017

Network for Evaluation of One Health

Associated One Health initiatives

“The national, international and global One Health initiatives and consortia described here are directly or indirectly associated with NEOH and form part of the global One Health ...”


UC Davis (USA) Commentary on G-20 Nations recommend adopting One Health Approach for Antimicrobial Resistance (AMR) - Wednesday, July 12, 2017

Michael Lairmore, Dean, Veterinary Medicine

Dean's Musings

Addressing Societal Needs by Combating Antimicrobial Resistance

By Michael Lairmore On July 11, 2017

 “Infectious disease exists at this intersection between real science, medicine, public health, social policy, and human conflict.” – Andrea Barrett

As part of our school’s vision, we seek to address societal needs. In challenging ourselves to this daunting task of working to solve the most vexing problems our world faces, we find our people and programs drawn toward the interface of science, public health, and policy. In opening remarks at the recent G20 Conference, Angel Gurría, Secretary-General of the Organization for Economic Co-operation and Development, praised Germany Chancellor Angela Merkel for recognizing that antimicrobial resistance (AMR) is a major threat to the health of the world’s populations and the future of economies of the many countries.

He indicated that as many as 700,000 people worldwide are already dying each year because of drug-resistant infections and that the cumulative economic cost of AMR will reach 100 trillion dollars by 2050, a cost primarily borne by low and middle income countries. The Secretary-General went on to suggest that “by implementing existing international commitments and recommendations of the World Health Organization, Food and Agriculture Organization of the United Nations and World Organization for Animal Health, countries can promote a more appropriate use of antimicrobials in a true ‘One Health’ framework.”

Antimicrobial resistance is an example of a major societal issue that our school has been making significant efforts to understand and combat. These efforts include forming partnerships with state and national organizations to inform stakeholders on a new Food and Drug Administration Guidance on the use of antimicrobials, to working with the California Veterinary Medical Association and the California Department of Food and Agriculture to develop evidence-based science policies in California to ensure the proper use of antimicrobials to advance animal health, while not overusing important human drugs for growth promotion as feed additives.

Dr. Terry Lehenbauer, director of the UC Davis Veterinary Medical Teaching and Research Center in Tulare, participated in a recent American Public and Land-grant University/American Association of Veterinary Medical Colleges Working Group to develop antimicrobial resistance curriculum learning outcomes, which were featured at a U.S. Capitol Hill Briefing. We have successfully competed for a new cooperative extension specialist faculty position focused on antimicrobial resistance research and outreach. This new faculty member will join a comprehensive group of faculty members who are studying AMR from multiple vantage points to address this important health threat.

The California Animal Health & Food Safety Laboratory (CAHFS) in Tulare, a diagnostic laboratory devoted to protecting farm animals, the food supply and the public against new and emerging diseases. The Tulare facility is one of four labs in the California Animal Health and Food Safety Laboratory System, headquartered at UC Davis and operated for the state by the veterinary school to protect animal health and performance, and safeguard public health and the food supply.

Our California Animal Health and Food Safety laboratory diagnosticians and scientist are actively seeking ways to monitor drug-resistant bacteria in our food supply. Our scientists are using the latest technologies to genetically analyze food-borne pathogens, especially those that may be resistant to commonly used antibiotics. Our school has partnered with the Farm Foundation to bring together the state’s livestock and poultry producers, their feed suppliers and veterinarians to discuss the changing landscape of antibiotic drug use in food animals. Knowledge related to the proper use of antibiotics is then offered to our stakeholders throughout the State of California via our cooperative extension faculty through conferences, proceedings, and other public outreach efforts.

Collectively, our people and programs are on the front lines of counteracting AMR, exemplifying our vision to address this pressing societal need. In doing so, we are in lock-step with other G20 countries committed to promoting the appropriate use of antimicrobials through a One Health approach.

Please see link for full article:

Provided by: 

Michael D. Lairmore DVM, PhD

Dean and Distinguished Professor

School of Veterinary Medicine

University of California – Davis

One Shields Avenue

Davis, CA 95616

Tel (530) 752-1361

Fax (530) 752-2801


Twitter: @LairmoreDVMDean

Note:  Dr. Lairmore is a longstanding One Health leader and champion


One Health Initiative
Home | About One Health | Mission Statement | One Health News | AVMA Task Force Report | One Health Newsletter |
Publications | Supporters | Supporter Endorsements | Upcoming Events | Contact Us